Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2016

Open Access 01-12-2016 | Research

Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity

Authors: Joice Monaliza Vernini, Jusciéle Brogin Moreli, Roberto Antônio Araújo Costa, Carlos Antonio Negrato, Marilza Vieira Cunha Rudge, Iracema Mattos Paranhos Calderon

Published in: Diabetology & Metabolic Syndrome | Issue 1/2016

Login to get access

Abstract

Background

Maternal obesity is associated with several adverse pregnancy outcomes. This study was conducted aiming to evaluate maternal levels of adipokines and insulin in pregnancies complicated by overweight and obesity and its correlations with maternal and fetal outcomes.

Methods

This cross-sectional study included 72 mother–newborn pairs. Mothers were classified as having normal weight (n = 23), overweight (n = 18), and obesity (n = 31). Maternal adiponectin, leptin, resistin and insulin levels at the end of pregnancy were compared among groups and correlated with maternal and perinatal outcomes. Data were analyzed by ANOVA and correlation tests, with a p value <0.05 being considered as significant.

Results

Obese pregnant women showed higher leptin levels (p = 0.0021). Leptin levels were positively correlated with prepregnancy body mass index—BMI (r = 0.57), gestational (37 or 38 weeks of gestation) BMI (r = 0.39), hypertension (r = 0.27), and hyperglycemia (r = 0.30), and negatively associated with newborns’ abdominal circumference (r = −0.25). Adiponectin concentrations were negatively correlated with gestational BMI (r = −0.29) and newborns’ cephalic circumference (r = −0.27) and positively correlated with birth weight (r = 0.23). Insulin concentrations correlated positively with prepregnancy BMI (r = 0.38), gestational BMI (r = 0.24) and maternal hyperglycemia (r = 0.26).

Conclusions

Our findings support the relationship between markers of obesity and maternal–fetal outcomes. Maternal insulin and adipokines levels showed an independent relationship with mother and newborns outcomes, respectively. In this studied population, the results indirectly reinforce the importance of maternal weight control before and during pregnancy to avoid adverse outcomes to mother and their newborns.
Literature
1.
go back to reference Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347–55.CrossRefPubMed Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92:347–55.CrossRefPubMed
2.
go back to reference Eriksson B, Lof M, Olausson H, Forsum E. Body fat, insulin resistance, energy expenditure and serum concentrations of leptin, adiponectin and resistin before, during and after pregnancy in healthy Swedish women. Br J Nutr. 2010;103:50–7.CrossRefPubMed Eriksson B, Lof M, Olausson H, Forsum E. Body fat, insulin resistance, energy expenditure and serum concentrations of leptin, adiponectin and resistin before, during and after pregnancy in healthy Swedish women. Br J Nutr. 2010;103:50–7.CrossRefPubMed
3.
go back to reference Svensson H, Wetterling L, Bosaeus M, Odén B, Odén A, Jennische E, Edén S, Holmäng A, Lönn M. Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance. Int J Obes. 2016;40:646–53.CrossRef Svensson H, Wetterling L, Bosaeus M, Odén B, Odén A, Jennische E, Edén S, Holmäng A, Lönn M. Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance. Int J Obes. 2016;40:646–53.CrossRef
4.
go back to reference Rajala MW, Scherer PE. Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765–73.CrossRefPubMed Rajala MW, Scherer PE. Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765–73.CrossRefPubMed
5.
go back to reference Zavalza-Gomez AB, Anaya-Prado R, Rinconsanchez AR, Mora-Martinez JM. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80:8–15.CrossRefPubMed Zavalza-Gomez AB, Anaya-Prado R, Rinconsanchez AR, Mora-Martinez JM. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80:8–15.CrossRefPubMed
6.
go back to reference Madan JC, Damman O, Allan W, Quinn R, Davis J. Maternal obesity and markers of inflammation and pregnancy. Cytokine. 2009;47:61–4.CrossRefPubMed Madan JC, Damman O, Allan W, Quinn R, Davis J. Maternal obesity and markers of inflammation and pregnancy. Cytokine. 2009;47:61–4.CrossRefPubMed
7.
go back to reference Lowe LP, Metzger BE, Lowe WL Jr, Dyer AR, McDade TW, McIntyre HD. Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab. 2010;95:5427–34.CrossRefPubMedPubMedCentral Lowe LP, Metzger BE, Lowe WL Jr, Dyer AR, McDade TW, McIntyre HD. Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab. 2010;95:5427–34.CrossRefPubMedPubMedCentral
8.
go back to reference Atègbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91:4137–43.CrossRefPubMed Atègbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91:4137–43.CrossRefPubMed
9.
go back to reference Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16:921–37.CrossRefPubMed Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16:921–37.CrossRefPubMed
10.
go back to reference D’Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. BioFactors. 2012;38:14–23.CrossRefPubMed D’Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. BioFactors. 2012;38:14–23.CrossRefPubMed
11.
go back to reference Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediat Inflamm. 2010. doi:10.1155/2010/513948. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediat Inflamm. 2010. doi:10.​1155/​2010/​513948.
12.
go back to reference Haugen F, Ranheim T, Harsem NK, et al. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab. 2006;290:326–33.CrossRef Haugen F, Ranheim T, Harsem NK, et al. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab. 2006;290:326–33.CrossRef
13.
go back to reference Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49:1677–85.CrossRefPubMed Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49:1677–85.CrossRefPubMed
14.
go back to reference Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67:341–7.CrossRefPubMed Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67:341–7.CrossRefPubMed
15.
go back to reference Lacroix M, Kina E, Hivert MF. Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep. 2013;13:238–44.CrossRefPubMed Lacroix M, Kina E, Hivert MF. Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep. 2013;13:238–44.CrossRefPubMed
16.
go back to reference Briana DD, Boutsikou M, Gourgiotis D, et al. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. J Perinat Med. 2007;35:326–9.CrossRefPubMed Briana DD, Boutsikou M, Gourgiotis D, et al. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. J Perinat Med. 2007;35:326–9.CrossRefPubMed
18.
go back to reference Lecke SB, Morsch DM, Spritzer PM. Leptin and adiponectin in the female life course. Braz J Med Biol Res. 2011;44:381–7.CrossRefPubMed Lecke SB, Morsch DM, Spritzer PM. Leptin and adiponectin in the female life course. Braz J Med Biol Res. 2011;44:381–7.CrossRefPubMed
19.
go back to reference Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A. Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res. 2012;40:583–9.CrossRefPubMed Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A. Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res. 2012;40:583–9.CrossRefPubMed
20.
go back to reference Skvarca A, Tomazic M, Blagus R, Krhin B, Janez A. Adiponectin/leptin ratio and insulin resistance in pregnancy. J Int Med Res. 2013;41:123–8.CrossRefPubMed Skvarca A, Tomazic M, Blagus R, Krhin B, Janez A. Adiponectin/leptin ratio and insulin resistance in pregnancy. J Int Med Res. 2013;41:123–8.CrossRefPubMed
21.
go back to reference Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203.CrossRefPubMed Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203.CrossRefPubMed
22.
go back to reference Waxman A. Prevention of chronic diseases: WHO global strategy on diet, physical activity and health. Food Nutr Bull. 2003;24:281–4.CrossRefPubMed Waxman A. Prevention of chronic diseases: WHO global strategy on diet, physical activity and health. Food Nutr Bull. 2003;24:281–4.CrossRefPubMed
23.
go back to reference Retnakaran R, Qi Y, Connelly PW, et al. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia. 2010;53:268–76.CrossRefPubMed Retnakaran R, Qi Y, Connelly PW, et al. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia. 2010;53:268–76.CrossRefPubMed
24.
go back to reference WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneva: World Health Organization; 2000. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneva: World Health Organization; 2000.
25.
go back to reference Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Atenção ao pré-natal de baixo risco/Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. – Brasília: Editora do Ministério da Saúde, 2012. p. 318. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Atenção ao pré-natal de baixo risco/Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. – Brasília: Editora do Ministério da Saúde, 2012. p. 318.
26.
go back to reference Atalah SE, Castilho LC, Castro SR, Aldea PA. Propuesta de um nuevo estándar de evalución nutricional en embarazadas. Rev Med Chil. 1997;125:1429–36.PubMed Atalah SE, Castilho LC, Castro SR, Aldea PA. Propuesta de um nuevo estándar de evalución nutricional en embarazadas. Rev Med Chil. 1997;125:1429–36.PubMed
27.
go back to reference Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al. Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27:691–7. Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al. Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27:691–7.
28.
29.
go back to reference Rudge MV, Calderon IM, Ramos MD, Abbade JF, Rugolo LM. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Investig. 2000;50:108–12.CrossRef Rudge MV, Calderon IM, Ramos MD, Abbade JF, Rugolo LM. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Investig. 2000;50:108–12.CrossRef
30.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl 1):S1–90. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl 1):S1–90.
32.
go back to reference Bo S, Menato G, Gallo ML, et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand. 2004;83:335–40.CrossRefPubMed Bo S, Menato G, Gallo ML, et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand. 2004;83:335–40.CrossRefPubMed
33.
go back to reference Negrato CA, Javanovic L, Tambascia MA, et al. Mild gestational hyperglycemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24:324–30.CrossRefPubMed Negrato CA, Javanovic L, Tambascia MA, et al. Mild gestational hyperglycemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24:324–30.CrossRefPubMed
34.
go back to reference Negrato CA, Javanovic L, Tambascia MA, et al. Association between insulin resistance, glucose intolerance, and hypertension in pregnancy. Metab Syndr Relat Disord. 2009;7:53–9.CrossRefPubMed Negrato CA, Javanovic L, Tambascia MA, et al. Association between insulin resistance, glucose intolerance, and hypertension in pregnancy. Metab Syndr Relat Disord. 2009;7:53–9.CrossRefPubMed
35.
go back to reference Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–11.CrossRefPubMed Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–11.CrossRefPubMed
36.
37.
go back to reference Di Simone N, Di Nicuolom F, Marzioni D, et al. Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells. J Cell Mol Med. 2009;13:388–97.CrossRefPubMed Di Simone N, Di Nicuolom F, Marzioni D, et al. Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells. J Cell Mol Med. 2009;13:388–97.CrossRefPubMed
38.
go back to reference Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res. 2011;37:112–8.CrossRefPubMed Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res. 2011;37:112–8.CrossRefPubMed
39.
go back to reference Akdeniz N, Kuyumcuoglu U, Kale A, Arikan S, Kele E, Erdemoglu M. Resistin may not associate with gestational diabetes mellitus although insulin resistance. Clin Exp Obstet Gynecol. 2011;38:236–8.PubMed Akdeniz N, Kuyumcuoglu U, Kale A, Arikan S, Kele E, Erdemoglu M. Resistin may not associate with gestational diabetes mellitus although insulin resistance. Clin Exp Obstet Gynecol. 2011;38:236–8.PubMed
40.
go back to reference Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.CrossRefPubMed Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.CrossRefPubMed
42.
go back to reference Jansson N, Nilsfelt A, Gellerstedt M, Wennergren M, Rossander-Hulthen L, Powell TL, et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008;87:1743–9.PubMed Jansson N, Nilsfelt A, Gellerstedt M, Wennergren M, Rossander-Hulthen L, Powell TL, et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008;87:1743–9.PubMed
43.
go back to reference Aye ILMH, Powell TL, Jansson T. Review: adiponectin—the missing link between maternal adiposity, placental transport and fetal growth? Placenta. 2013;34:S40–5.CrossRefPubMed Aye ILMH, Powell TL, Jansson T. Review: adiponectin—the missing link between maternal adiposity, placental transport and fetal growth? Placenta. 2013;34:S40–5.CrossRefPubMed
44.
go back to reference Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus complicated pregnancies. J Endocrinol. 2005;186:457–65.CrossRefPubMed Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus complicated pregnancies. J Endocrinol. 2005;186:457–65.CrossRefPubMed
45.
go back to reference Wang J, Wang SH, Shang LX, et al. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res. 2010;36:533–7.CrossRefPubMed Wang J, Wang SH, Shang LX, et al. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res. 2010;36:533–7.CrossRefPubMed
46.
go back to reference Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and fetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66:447–53.CrossRef Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and fetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66:447–53.CrossRef
47.
go back to reference Ornoy A. Biomarkers of maternal diabetes and its complication in pregnancy. Reprod Toxicol. 2012;34:174–9.CrossRefPubMed Ornoy A. Biomarkers of maternal diabetes and its complication in pregnancy. Reprod Toxicol. 2012;34:174–9.CrossRefPubMed
Metadata
Title
Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity
Authors
Joice Monaliza Vernini
Jusciéle Brogin Moreli
Roberto Antônio Araújo Costa
Carlos Antonio Negrato
Marilza Vieira Cunha Rudge
Iracema Mattos Paranhos Calderon
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2016
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-016-0184-y

Other articles of this Issue 1/2016

Diabetology & Metabolic Syndrome 1/2016 Go to the issue